Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages.
about
Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapyHarnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.Intracellular bacillary burden reflects a burst size for Mycobacterium tuberculosis in vivo.Cytosolic, autocrine alpha-1 proteinase inhibitor (A1PI) inhibits caspase-1 and blocks IL-1β dependent cytokine release in monocytes.Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapyDiminished Memory T-Cell Expansion Due to Delayed Kinetics of Antigen Expression by Lentivectors.Ozone inhalation promotes CX3CR1-dependent maturation of resident lung macrophages that limit oxidative stress and inflammation.Inhibition of p-IκBα Ubiquitylation by Autophagy-Related Gene 7 to Regulate Inflammatory Responses to Bacterial InfectionMitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice.Airway gene transfer in a non-human primate: lentiviral gene expression in marmoset lungs.Multilineage transduction of resident lung cells in vivo by AAV2/8 for α1-antitrypsin gene therapy.Mycobacterium leprae Activates Toll-Like Receptor-4 Signaling and Expression on Macrophages Depending on Previous Bacillus Calmette-Guerin VaccinationPreparation for a first-in-man lentivirus trial in patients with cystic fibrosis.High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors.JNK suppresses pulmonary fibroblast elastogenesis during alveolar development.Current status and future directions of gene and cell therapy for cystic fibrosis.Elastase-induced pulmonary emphysema: insights from experimental models.Expert opinion in biological therapy: update on developments in lung gene transfer.Current status of gene therapy for α-1 antitrypsin deficiency.Lung surfactant metabolism: early in life, early in disease and target in cell therapy.Lentiviral delivery of RNAi for in vivo lineage-specific modulation of gene expression in mouse lung macrophages.Emergence of a stage-dependent human liver disease signature with directed differentiation of alpha-1 antitrypsin-deficient iPS cells.TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis.Brief report: VGLL4 is a novel regulator of survival in human embryonic stem cells.Construction of a lentiviral T/A vector for direct analysis of PCR-amplified promoters.Pulmonary research in 2013 and beyond: a National Heart, Lung, and Blood Institute perspective.Pluripotent stem cell differentiation reveals distinct developmental pathways regulating lung- versus thyroid-lineage specification.Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection.Alveolar-like Stem Cell-derived Myb(-) Macrophages Promote Recovery and Survival in Airway Disease.Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling.Practical Methods for Assessing Emphysema Severity Based on Estimation of Linear Mean Intercept (Lm) in the Context of Animal Models of Alpha-1 Antitrypsin Deficiency.[Study of the antitumor activity of alveolar macrophages after transfected human INF-γ gene].
P2860
Q28383844-54C0BEB9-5D36-4282-80FA-C2B9F9DA91DDQ30431135-F06FE119-40D0-4D44-9F9A-D2EFD32F9918Q30461932-577725E8-E1BB-427C-9A96-0672868A11EEQ31111660-F58266EE-B3CA-4FBE-B654-203707299F94Q34506289-307A0F2D-5D82-4327-BD25-2E158F596C42Q34642249-43862915-548A-49D0-81BB-71025E7DFFCAQ34792987-EFA6C241-C86B-49D4-92A5-A48036853B47Q35401796-00219604-73F3-49C3-9105-57C87DBC4D79Q36250214-1274FBFB-BC32-46C7-BF73-06D750051691Q36547252-90CD4E97-39EC-41FE-8D22-FFA16BAFAF17Q36612385-5457497B-41FE-4119-9CB6-CAF2003664BDQ37051733-776809BA-48C1-444B-A322-B819D068A039Q37075508-B0103E33-0D3E-445C-B124-A463FD43914EQ37616952-4C8C2018-37F1-45C1-9CE1-C1F62374454BQ37633995-07168E21-50E7-423E-8960-8BB1EC30CDCBQ37704671-93EB7688-75CF-4C35-A207-1518431BEE70Q37858512-9D119FE2-C0FF-4C36-8F64-FFDEEB0ED83FQ37967172-60018142-16C4-4AF4-BC56-AEA73463EA1DQ38071683-AFC057CE-0650-482F-A456-49660856A0A6Q38264336-4C2204AC-88A6-46CC-ACF0-A55ECAD5D0C1Q38991273-4F37E226-7800-4C86-AADA-D58248915867Q39590935-AFAB9D84-8C2E-41AC-8F11-BF06D728A99EQ40843065-5A2B30A5-F883-443E-9CD3-55D92DE3D35AQ40976804-A2201219-FC60-436E-995B-EC728D11A8D9Q41966353-1FB0DC09-6E9B-40C0-A700-82E751804A8CQ42201916-5C4DDBB7-02B1-4192-91B8-02AD09D9A642Q42399756-5E89D72D-D65F-4505-8B30-5E597AC6795AQ47744477-C7EF98E2-26C0-4411-8ED8-7AC4675BF424Q47999795-47CFC470-7E4B-4548-B4E3-5276C8557DCAQ50541698-6FB60FF2-7920-413D-8D9F-F31547EDD6DBQ52884838-36FCE521-D127-41D7-A795-8825BA167152Q54544630-E99EA537-4960-4218-BF98-7FC12FA8E889Q55448244-1F6F95A1-A6D5-4FEC-8AC5-79D6D261016D
P2860
Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@ast
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@en
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@nl
type
label
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@ast
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@en
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@nl
prefLabel
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@ast
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@en
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@nl
P2093
P2860
P50
P356
P1476
Amelioration of emphysema in m ...... ulmonary alveolar macrophages.
@en
P2093
Avi-Hai Hovav
Hiroshi Hamakawa
Letty W Kwok
Richard C Mulligan
Sreedevi Srinivasan
P2860
P304
P356
10.1172/JCI36666
P407
P577
2009-12-21T00:00:00Z